Rewiring dendritic cell function with CLEC9A and DEC205 CARs

Abstract Dendritic cells (DCs) are central orchestrators of anti-tumor immunity, yet their therapeutic utility has been limited by dysfunction and insufficient activation within solid tumors. Here, we report chimeric antigen receptor-engineered DCs (CAR-DCs) that potently prime T cells and reprogram the tumor microenvironment. We identify the intracellular domains of CLEC9A or DEC205 as essential for functional CAR-DC activity, enabling enhanced antigen uptake, cross-presentation, and robust cytokine production that drive strong T cell expansion and effector differentiation. Mechanistically, CARs incorporating CLEC9A or DEC205 intracellular domains triggered SYK phosphorylation and downstream signaling pathways. In both murine and humanized models, CAR-DC therapy suppressed tumor growth and promoted expansion of tumor-reactive T cells. These findings establish CAR-DCs as a scalable and clinically translatable platform for next-generation solid tumor immunotherapy.

Authors

Institutions

Publication Details

Journal
Nature Immunology
Published
2026-11-13
DOI
https://doi.org/10.1038/s41590-026-02711-3
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Rewiring dendritic cell function with CLEC9A and DEC205 CARs

Mikäel J. Pittet, Congyi Niu, Xiaoqiu Dai, Sudan He et al.
5 links
Nature Immunology
Immunotherapy and Immune Responses
article

Rewiring dendritic cell function with CLEC9A and DEC205 CARs

Mikäel J. Pittet, Congyi Niu, Xiaoqiu Dai, Sudan He, H Zhang, Yingxi Xu, Chen Wang, Lianjun Zhang, Peng Lin, He Gao, Xiaowen Tang, Hui Wang, Sudan He, Peng Lin, Yunju Ma, Zhen Xiao
article en

Abstract

Abstract Dendritic cells (DCs) are central orchestrators of anti-tumor immunity, yet their therapeutic utility has been limited by dysfunction and insufficient activation within solid tumors. Here, we report chimeric antigen receptor-engineered DCs (CAR-DCs) that potently prime T cells and reprogram the tumor microenvironment. We identify the intracellular domains of CLEC9A or DEC205 as essential for functional CAR-DC activity, enabling enhanced antigen uptake, cross-presentation, and robust cytokine production that drive strong T cell expansion and effector differentiation. Mechanistically, CARs incorporating CLEC9A or DEC205 intracellular domains triggered SYK phosphorylation and downstream signaling pathways. In both murine and humanized models, CAR-DC therapy suppressed tumor growth and promoted expansion of tumor-reactive T cells. These findings establish CAR-DCs as a scalable and clinically translatable platform for next-generation solid tumor immunotherapy.

Nature Immunology
University of Geneva (CH), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), University Hospital of Geneva (CH), Ludwig Cancer Research (CH), Suzhou Institute of Systems Medicine (CN), Institute of Hematology & Blood Diseases Hospital (CN), Swiss Cancer Center Léman (CH), First Affiliated Hospital of Soochow University (CN)
National Science Foundation, Ludwig Institute for Cancer Research, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, National Natural Science Foundation of China, Government of Jiangsu Province, Natural Science Foundation of Jiangsu Province, Hyderabad Eye Research Foundation, Hôpitaux Universitaires de Genève, Fondation ISREC, Basic Research Program of Jiangsu Province, National Key Research and Development Program of China
Good health and well-being
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon